Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back

Katherine A. Rauen, Lisa Schoyer, Frank McCormick, Angela E. Lin, Judith E. Allanson, David A. Stevenson, Karen W. Gripp, Giovanni Neri, John C. Carey, Eric Legius, Marco Tartaglia, Suzanne Schubbert, Amy E. Roberts, Bruce D. Gelb, Kevin Shannon, David H. Gutmann, Martin McMahon, Carmen Guerra, James A. Fagin, Benjamin YuYoko Aoki, Benjamin G. Neel, Allan Balmain, Richard R. Drake, Garry P. Nolan, Martin Zenker, Gideon Bollag, Judith Sebolt-Leopold, Jackson B. Gibbs, Alcino J. Silva, E. Elizabeth Patton, David H. Viskochil, Mark W. Kieran, Bruce R. Korf, Randi J. Hagerman, Roger J. Packer, Teri Melese

Research output: Contribution to journalArticlepeer-review

79 Scopus citations


The RASopathies are a group of genetic syndromes caused by germline mutations in genes that encode components of the Ras/ mitogen-activated protein kinase (MAPK) pathway. Some of these syndromes are neurofibromatosis type 1, Noonan syndrome, Costello syndrome, cardio-facio-cutaneous syndrome, LEOPARD syndrome and Legius syndrome. Their common underlying pathogenetic mechanism brings about significant overlap in phenotypic features and includes craniofacial dysmorphology, cardiac, cutaneous, musculoskeletal, GI and ocular abnormalities, and a predisposition to cancer. The proceedings from the symposium "Genetic Syndromes of the Ras/MAPK Pathway: From Bedside to Bench and Back" chronicle the timely and typical research symposium which brought together clinicians, basic scientists, physician-scientists, advocate leaders, trainees, students and individuals with Ras syndromes and their families. The goals, to discuss basic science and clinical issues, to set forth a solid framework for future research, to direct translational applications towards therapy and to set forth best practices for individuals with RASopathies were successfully meet with a commitment to begin to move towards clinical trials.

Original languageEnglish
Pages (from-to)4-24
Number of pages21
JournalAmerican Journal of Medical Genetics, Part A
Issue number1
StatePublished - Jan 2010


  • Cardio-facio-cutaneous syndrome
  • Clinical trial
  • Costello syndrome
  • Legius syndrome
  • Neurofibromatosis type 1
  • Noonan syndrome
  • RASopathy
  • Ras/MAPK
  • Signal transduction pathway
  • Therapy


Dive into the research topics of 'Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back'. Together they form a unique fingerprint.

Cite this